Skip to main content
Top
Published in: Annals of Hematology 12/2013

01-12-2013 | Original Article

Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea

Authors: Young Wha Koh, Hyo Jeong Kang, Dok Hyun Yoon, Cheolwon Suh, Ji Eun Kim, Chul-Woo Kim, Jooryung Huh

Published in: Annals of Hematology | Issue 12/2013

Login to get access

Abstract

Hodgkin lymphoma (HL) in resource-poor population shows an early childhood peak with predominance of mixed cellularity (MCHL) and high Epstein-Barr virus (EBV) association, whereas HL in resource-rich population has a peak in ages 15–29 years with the predominance of nodular sclerosis (NSHL) and low EBV association. We examined the changing trend of HL in association with EBV in Korea in 385 cases of HL (1980–2011). Data from 1980–1995 and 1996–2011 were compared. Age distribution showed a marked decrease in children (age < 15 years) (21.0 % to 8.6 %, p = 0.004) and sharp increase in young adults (ages 15–29 years) and ages 30–59 years. Male predominance decreased from 3.04 to 1.57. Predominant subtype changed from MCHL to NSHL; MCHL fell from 53.3 % to 26.4 % (p < 0.001), and NSHL rose from 24.8 % to 58.2 % (p < 0.001). EBV-positive HL decreased from 66.7 % to 38.2 %. However, in young adult females, EBV positive cases increased, contributing to the peak in this age group. Epidemiology of HL in Korea is rapidly changing into a Western pattern concurrent with the socioeconomic changes. Analysis of the cases stratified by EBV status and sex identified a smaller hidden peak in the young adult age, which confirms the four disease hypothesis proposed by Jarrett. We propose EBV testing as an essential component in epidemiologic study of Hodgkin lymphoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Curado MP (2007) International Agency for Research on Cancer, International Association of Cancer Registries. Cancer incidence in five continents vol. IX. IARC Press, Lyon, France Curado MP (2007) International Agency for Research on Cancer, International Association of Cancer Registries. Cancer incidence in five continents vol. IX. IARC Press, Lyon, France
2.
go back to reference MacMahon B (1966) Epidemiology of Hodgkin's disease. Cancer Res 26(6):1189–1201PubMed MacMahon B (1966) Epidemiology of Hodgkin's disease. Cancer Res 26(6):1189–1201PubMed
3.
go back to reference Correa P, O'Conor GT (1971) Epidemiologic patterns of Hodgkin's disease. Int J Cancer 8(2):192–201PubMedCrossRef Correa P, O'Conor GT (1971) Epidemiologic patterns of Hodgkin's disease. Int J Cancer 8(2):192–201PubMedCrossRef
4.
go back to reference Glaser SL, Jarrett RF (1996) The epidemiology of Hodgkin's disease. Bailliere Clin Haematol 9(3):401–416CrossRef Glaser SL, Jarrett RF (1996) The epidemiology of Hodgkin's disease. Bailliere Clin Haematol 9(3):401–416CrossRef
5.
go back to reference Jarrett AF, Armstrong AA, Alexander E (1996) Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 7(Suppl 4):5–10PubMedCrossRef Jarrett AF, Armstrong AA, Alexander E (1996) Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 7(Suppl 4):5–10PubMedCrossRef
6.
go back to reference Macfarlane GJ, Evstifeeva T, Boyle P, Grufferman S (1995) International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int J Cancer 61(2):165–169PubMedCrossRef Macfarlane GJ, Evstifeeva T, Boyle P, Grufferman S (1995) International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int J Cancer 61(2):165–169PubMedCrossRef
7.
go back to reference Glaser SL, Hsu JL (2002) Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data. Leuk Res 26(3):261–269PubMedCrossRef Glaser SL, Hsu JL (2002) Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data. Leuk Res 26(3):261–269PubMedCrossRef
8.
go back to reference Gutensohn N, Cole P (1981) Childhood social environment and Hodgkin's disease. N Engl J Med 304(3):135–140PubMedCrossRef Gutensohn N, Cole P (1981) Childhood social environment and Hodgkin's disease. N Engl J Med 304(3):135–140PubMedCrossRef
9.
go back to reference Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens—part B: biological agents. Lancet Oncol 10(4):321–322PubMedCrossRef Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens—part B: biological agents. Lancet Oncol 10(4):321–322PubMedCrossRef
10.
go back to reference Glaser SL, Gulley ML, Clarke CA, Keegan TH, Chang ET, Shema SJ, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Anton-Culver H, Ambinder RF (2008) Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer 123(7):1499–1507. doi:10.1002/ijc.23741 PubMedCrossRef Glaser SL, Gulley ML, Clarke CA, Keegan TH, Chang ET, Shema SJ, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Anton-Culver H, Ambinder RF (2008) Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer 123(7):1499–1507. doi:10.​1002/​ijc.​23741 PubMedCrossRef
12.
go back to reference Takeuchi K, Morishita Y, Fukayama M, Mori S (2001) Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin's disease in Tokyo: trend between 1955 and 1999. Br J Haematol 113(2):429–431PubMedCrossRef Takeuchi K, Morishita Y, Fukayama M, Mori S (2001) Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin's disease in Tokyo: trend between 1955 and 1999. Br J Haematol 113(2):429–431PubMedCrossRef
13.
go back to reference Au WY, Gascoyne RD, Gallagher RE, Le N, Klasa RD, Liang RH, Choy C, Foo W, Connors JM (2004) Hodgkin's lymphoma in Chinese migrants to British Columbia: a 25-year survey. Ann Oncol 15(4):626–630PubMedCrossRef Au WY, Gascoyne RD, Gallagher RE, Le N, Klasa RD, Liang RH, Choy C, Foo W, Connors JM (2004) Hodgkin's lymphoma in Chinese migrants to British Columbia: a 25-year survey. Ann Oncol 15(4):626–630PubMedCrossRef
14.
go back to reference Chang KC, Chen PC, Jones D, Su IJ (2008) Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan. Cancer Sci 99(2):345–349PubMedCrossRef Chang KC, Chen PC, Jones D, Su IJ (2008) Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan. Cancer Sci 99(2):345–349PubMedCrossRef
16.
go back to reference Huh J, Park C, Juhng S, Kim CE, Poppema S, Kim C (1996) A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection. Cancer 77(5):949–955PubMedCrossRef Huh J, Park C, Juhng S, Kim CE, Poppema S, Kim C (1996) A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection. Cancer 77(5):949–955PubMedCrossRef
18.
go back to reference Armstrong AA, Alexander FE, Cartwright R, Angus B, Krajewski AS, Wright DH, Brown I, Lee F, Kane E, Jarrett RF (1998) Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 12(8):1272–1276PubMedCrossRef Armstrong AA, Alexander FE, Cartwright R, Angus B, Krajewski AS, Wright DH, Brown I, Lee F, Kane E, Jarrett RF (1998) Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 12(8):1272–1276PubMedCrossRef
20.
go back to reference Jarrett RF, Stark GL, White J, Angus B, Alexander FE, Krajewski AS, Freeland J, Taylor GM, Taylor PR (2005) Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood 106(7):2444–2451PubMedCrossRef Jarrett RF, Stark GL, White J, Angus B, Alexander FE, Krajewski AS, Freeland J, Taylor GM, Taylor PR (2005) Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood 106(7):2444–2451PubMedCrossRef
21.
go back to reference Yoon SO, Suh C, Lee DH, Chi HS, Park CJ, Jang SS, Shin HR, Park BH, Huh J (2010) Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification. Am J Hematol 85(10)):760–764. doi:10.1002/ajh.21824 PubMedCrossRef Yoon SO, Suh C, Lee DH, Chi HS, Park CJ, Jang SS, Shin HR, Park BH, Huh J (2010) Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification. Am J Hematol 85(10)):760–764. doi:10.​1002/​ajh.​21824 PubMedCrossRef
Metadata
Title
Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea
Authors
Young Wha Koh
Hyo Jeong Kang
Dok Hyun Yoon
Cheolwon Suh
Ji Eun Kim
Chul-Woo Kim
Jooryung Huh
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 12/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1837-7

Other articles of this Issue 12/2013

Annals of Hematology 12/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.